BMI
Citrus flavonoid supplementation with metformin → BMI
Citrus flavonoid supplementation with metformin → BMI
Evidence profile
Key finding
The nutraceutical group demonstrated a 5% reduction in 2-h OGTT glucose.
Citrus bioflavonoid-based nutraceutical added to metformin in prediabetic individuals.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Citrus flavonoid supplementation with metformin, Placebo plus metformin
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Primary outcome
Postprandial glucose metabolism
Comparator
Group B
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
Citrus bioflavonoid-based nutraceutical added to metformin in prediabetic individuals.
This study evaluated Citrus bioflavonoid-based nutraceutical added to metformin in prediabetic individuals.
Limitations were not clearly described in the extracted text.
Published in
Publication details and source links for this paper.
Thais C, Maria RO, Valeria S, et al. Efficacy of Citrus Bioflavonoids as an Adjunct to Metformin Therapy in Prediabetic Individuals. Frontiers in Nutrition. 2025;12:1639901. doi:10.3389/fnut.2025.1639901
Save this study and add notes to your research library.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Citrus flavonoid supplementation with metformin and BMI, Body fat mass, Body weight, and 5 more.
This study contributes evidence to
Primary intervention
Citrus flavonoid supplementation with metformin
Primary outcomes
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
4
Related topics
8
Evidence pairs
240
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Citrus flavonoid supplementation with metformin → BMI
Citrus flavonoid supplementation with metformin → BMI
Evidence profile
Citrus flavonoid supplementation with metformin → Body fat mass
Citrus flavonoid supplementation with metformin → Body fat mass
Evidence profile
Citrus flavonoid supplementation with metformin → Body weight
Citrus flavonoid supplementation with metformin → Body weight
Evidence profile
Citrus flavonoid supplementation with metformin → GLP-1
Citrus flavonoid supplementation with metformin → GLP-1
Evidence profile
Citrus flavonoid supplementation with metformin → Plasma antioxidant capacity (FRAP)
Citrus flavonoid supplementation with metformin → Plasma antioxidant capacity (FRAP)
Evidence profile
Citrus flavonoid supplementation with metformin → Postprandial blood glucose
Citrus flavonoid supplementation with metformin → Postprandial blood glucose
Evidence profile
Citrus flavonoid supplementation with metformin → Systolic blood pressure
Citrus flavonoid supplementation with metformin → Systolic blood pressure
Evidence profile
Citrus flavonoid supplementation with metformin → Tumor Necrosis Factor-alpha (TNF-α)
Citrus flavonoid supplementation with metformin → Tumor Necrosis Factor-alpha (TNF-α)
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Metformin Therapies and Body Mass Index, Metformin Therapies and Body Composition.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring Body Composition
Measures Body Composition as a key outcome.
All studies measuring Body Mass Index
Measures Body Mass Index as a key outcome.
All studies measuring Body Weight
Measures Body Weight as a key outcome.
All studies on Metformin Therapies
Contributes to Metformin Therapies evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Metformin Therapies appears to improve Blood Pressure.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Systolic blood pressure
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Metformin Therapies appears to improve Body Composition.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Body fat mass
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Metformin Therapies appears to improve Postprandial and OGTT Glucose.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Postprandial blood glucose
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Metformin Therapies appears to improve Inflammatory Markers.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Tumor Necrosis Factor-alpha (TNF-α)
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.